NCT03734926 A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT03693807 A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT03665285 A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03637569 The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer Status RECRUITING Phase N/A
NCT03603834 Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma Status UNKNOWN Phase PHASE2
NCT03602079 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Status COMPLETED Phase PHASE1/PHASE2
NCT03563352 Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer Status WITHDRAWN Phase N/A
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03499782 Precise Treatment System of Biliary Malignancies Based on Special Disease Database Status UNKNOWN Phase N/A
NCT03486678 SHR-1210 in Combination With GEMOX in Patients With Advanced BTC Status COMPLETED Phase PHASE2
NCT03473574 Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients Status COMPLETED Phase PHASE2
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Status RECRUITING Phase N/A
NCT03414489 Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®) Status NO_LONGER_AVAILABLE Phase N/A
NCT03377179 A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT03339843 Multiorgan Metabolic Imaging Response Assessment of Abemaciclib Status COMPLETED Phase PHASE2